Nintedanib has been designated a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma (MPM) by the UK Medicine and Healthcare Products Regulatory Agency (MHRA).

The Philippines has suspended clearance for Sanofi’s dengue vaccine Dengvaxia and fined the French drugmaker a symbolic $2,000 citing violations on product registration and marketing, the health secretary said on...

Voice-enabled search is one of the biggest topics in SEO circles, but many content marketers haven’t embraced the implications of virtual assistants and other voice-powered technology.
 

Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of Jean-Paul Kress. He leaves behind his position as EVP, President International and Head of Global Therapeutic...

Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, Restasis.
 

Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing agreement. The deal adds to previous agreements signed with MSD and Genentech, cementing...

Seattle Genetics’ Adcetris has received a boost after the US Food and Drug Administration’s (FDA) granted the lymphoma drug priority review status.

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the health service should fund GlaxoSmithKline’s gene therapy Strimvelis for the treatment of adenosine deaminase...